🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesSemaglutide cardiovascular benefit independent of weight loss — March 2026 Page 5

Semaglutide cardiovascular benefit independent of weight loss — March 2026

KevinCompounds Wed, Sep 11, 2024 at 8:02 PM 50 replies 2,983 viewsPage 5 of 10
Dr.MetabolicMD
VIP Member
2,345
16,789
Jan 2024
Rochester, MN
Sep 13, 2024 at 7:48 PM#21
DoseLogDan said:
For anyone assembling their own picture: Tmax is one to three days, terminal half-life about 165 to 170 hours, steady state at four to five weeks, and…

Positive "side effect" of cardiovascular risk: my blood pressure dropped so much that I'm now off lisinopril entirely! My cardiologist is thrilled.

If you're on BP meds and losing weight on a GLP-1, monitor your BP at home regularly. Hypotension symptoms (dizziness, lightheadedness when standing) mean your BP meds may need reduction. Don't wait for your next scheduled appointment — call your doctor.

Last edited: Sep 13, 2024 at 9:48 PM
33 6SleepDoc_PDX, RegAffairsDC, BiostatsBrad and 30 others
Reply Quote Save Share Report
AussieAnna
Member
678
2,890
Jun 2024
Sydney, AU
Sep 14, 2024 at 8:08 AM#22
DoseLogDan said:
For anyone assembling their own picture: Tmax is one to three days, terminal half-life about 165 to 170 hours, steady state at four to five weeks, and…

This answered a question I did not know how to ask. Printing the relevant bit and taking it with me.

34 7HPLC_Greg, LibrarianMeg, bri_stats and 31 others
Reply Quote Save Share Report
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Sep 14, 2024 at 8:28 PM#23

Clinical perspective, offered as context rather than as advice.

6 month update on cardiovascular risk: down 52 lbs, off blood pressure meds, A1C normalized. Genuinely life-changing.

Last edited: Sep 15, 2024 at 1:28 AM
35 8maya_sedona, stefan_berlin, Dr.EM_Chicago and 32 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
hans_munich
Member
534
2,345
Jul 2024
Munich, DE
Sep 15, 2024 at 8:48 AM#24
TrialTracker_MD said:
6 month update on cardiovascular risk: down 52 lbs, off blood pressure meds, A1C normalized.

Adding a me-too, because a thread of one person's experience is not much use. The detail I would add is minor and it is already implied above.

36 9tammy_FL, Dr.LipidDallas, alex_tucson and 33 others
Reply Quote Save Share Report
BariatricNurseD
Senior Member
1,678
7,234
Feb 2024
Dallas, TX
Online
Sep 15, 2024 at 9:09 PM#25
TrialTracker_MD said:
6 month update on cardiovascular risk: down 52 lbs, off blood pressure meds, A1C normalized.

Adding the part of the answer the thread has not reached. Steady state is the thing most people miss. The terminal half-life is about a week, so every dose step takes four to five weeks to fully express itself. Judging a step at day ten is judging the ascent, not the plateau, and it is the single commonest reason people escalate before they needed to.

Worth separating that from semaglutide, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

37 10Dr.EndoIndy, tom_AK, josh_phd_bmore and 34 others
Reply Quote Save Share Report
13456710

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register